DOCSLIB.ORG

ACPA – Stanford Resource Guide 2021 Edition

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ACPA – Stanford Resource Guide 2021 Edition 1 ACPA – Stanford Resource Guide To Chronic Pain Management An Integrated Guide to Comprehensive Pain Therapies 2021 Edition P.O Box 850 1070 Arastradero Road, Suite 200 Rocklin, CA 95677 Palo Alto, CA 94304 T: 800-533-3231 T: 650-724-9143 F: 916-652-8190 F: 650-725-9642 E: [email protected] E: Stanford Pain Medicine Feedback W: American Chronic Pain Association W: Stanford Division of Pain Medicine Twitter: @StanfordPain Copyright 2021 American Chronic Pain Association, Inc., and Stanford University Division of Pain Medicine All rights reserved. No portion of this book may be reproduced without permission of the American Chronic Pain Association, Inc., and Stanford University Division of Pain Medicine American Chronic Pain Association and Stanford University Division of Pain Medicine Copyright 2021 2 Table of Contents Preface ......................................................................................................................................................................................... 6 Updates to 2021 Edition.................................................................................................................................................................. 7 INTRODUCTION .............................................................................................................................................................................. 9 Glossary of Terms used in this Resource Guide ............................................................................................................................... 11 OVERVIEW OF CHRONIC PAIN AND ITS TREATMENT ......................................................................................................................... 13 WHAT DOES SUCCESSFUL PAIN TREATMENT LOOK LIKE? ................................................................................................................. 15 PAIN DEFINITION AND TYPES ......................................................................................................................................................... 17 PAIN TERMS & TYPES .................................................................................................................................................................... 18 PAIN IN SPECIAL POPULATIONS ..................................................................................................................................................... 20 Pain in Older Persons ................................................................................................................................................................. 20 Pain in Pregnancy ...................................................................................................................................................................... 22 Pain in Children and Adolescents................................................................................................................................................. 24 PELVIC PAIN ................................................................................................................................................................................ 27 MAJOR TYPES OF INTERVENTIONS FOR PAIN .................................................................................................................................. 30 FUNCTIONAL RESTORATION APPROACHES & PROGRAMS ................................................................................................................. 31 SELF-DIRECTED GROUP AND SELF-MANAGEMENT ........................................................................................................................... 33 Self-Care, Self-Management, Self-Development ........................................................................................................................... 33 ACPA Groups.............................................................................................................................................................................. 33 Classes in Chronic Pain & Chronic Disease Self-Management ......................................................................................................... 34 ACTIVE INTERVENTIONS ............................................................................................................................................................... 35 Pain Education Information: Retraining the Body and the Mind ..................................................................................................... 35 Physical Activity & Exercising...................................................................................................................................................... 36 Aquatic Exercise ........................................................................................................................................................................ 36 Yoga ......................................................................................................................................................................................... 38 Pilates ...................................................................................................................................................................................... 38 Desensitization Therapy ............................................................................................................................................................. 39 Postural Awareness Exercise....................................................................................................................................................... 40 Functional Activity Training ........................................................................................................................................................ 41 Adjunctive Therapies ................................................................................................................................................................. 41 Personal Goal Attainment Program (PGAP®) ................................................................................................................................. 44 Chronic Pain Self-Management Program (CPSMP) ........................................................................................................................ 44 Cognitive Behavioral Therapy for Pain (Pain-CBT) ........................................................................................................................ 45 Acceptance and Commitment Therapy (ACT) ................................................................................................................................ 47 Motivational Interviewing .......................................................................................................................................................... 47 Fear Avoidance Therapy ............................................................................................................................................................. 48 Stress-reducing Interventions..................................................................................................................................................... 49 Mindfulness-based Stress Reduction (MBSR) and Meditation ......................................................................................................... 50 Guided Imagery ......................................................................................................................................................................... 51 Art & Music ................................................................................................................................................................................ 52 Biofeedback .............................................................................................................................................................................. 52 Hypnosis ................................................................................................................................................................................... 53 Reconditioning Brain and Mind ................................................................................................................................................... 53 NUTRITION .................................................................................................................................................................................. 57 COMPLEMENTARY, ALTERNATIVE & INTEGRATIVE MEDICINE (CAM) ................................................................................................... 57 Traditional Chinese Medicine (TCM) ............................................................................................................................................. 59 ACUPUNCTURE and ACUPRESSURE ................................................................................................................................................ 60 PHYSICAL MODALITIES – NONINVASIVE INTERVENTIONS ................................................................................................................. 63 American Chronic Pain Association and Stanford University Division of Pain Medicine Copyright 2021 3 INVASIVE INTERVENTIONS ............................................................................................................................................................ 71 MEDICATION
Load more

Recommended publications
  • Laura Charlton Corrected Thesis
    DOES SOCIAL CONTRACTING INFLUENCE THE JUDGEMENT OF CHILDREN’S PAIN? Laura Charlton Submitted in accordance with the requirements for the degree of Doctor of Clinical Psychology (D. Clin. Psychol.) The University of Leeds Academic Unit of Psychiatry and Behavioural Sciences School of Medicine September 2011 2 The candidate confirms that the work submitted is her own and that appropriate credit has been given where reference has been made to the work of others This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. 3 ACKNOWLEDGEMENTS I would like to thank my supervisors Professor Stephen Morley and Professor José Closs for taking on this project and helping me to make my project ideas into a reality. Thank you for being accepting of my last minute style and tolerating my procrastination techniques, which included getting engaged and married when I should have been collecting data. Secondly, I would like to thank the nursing students for their participation in my project. The School of Healthcare were very accommodating and I would like to acknowledge and thank Mandy Driffield, Michelle Green and Melanie Robbins for helping me recruit participants and allowing me time to carry out my project during the busy nursing timetable. I am extremely grateful to Dr Leisbet Goubert and Dr Tine Vervoort for providing the images that were needed for this project in such a timely fashion. I would also like to thank Dr Amanda C de C Williams for the helpful comments on my project.
    [Show full text]
  • CS/CS/HB 1373 Persons with Developmental Disabilities
    HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: CS/CS/HB 1373 Persons with Developmental Disabilities SPONSOR(S): Health & Human Services Committee; Children, Families & Seniors Subcommittee; Stevenson TIED BILLS: IDEN./SIM. BILLS: CS/SB 1788 REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF 1) Children, Families & Seniors Subcommittee 9 Y, 0 N, As CS Gilani Brazzell 2) Health & Human Services Committee 16 Y, 0 N, As Gilani Calamas CS SUMMARY ANALYSIS The Agency for Persons with Disabilities (APD) is responsible for providing services to persons with developmental disabilities. Persons with developmental disabilities reside in various types of residential settings, including community-based residential facilities licensed and regulated by APD. Medication services are an important element of care for individuals with developmental disabilities in APD facilities and are often provided by unlicensed direct service providers (DSPs). Medication assistance or administration typically involves observation of the client to ensure correct self- administration of medication, or directly giving or applying the medication as prescribed, respectively. Medication administration is generally a nurse’s responsibility; however, a majority of states, including Florida, allows trained unlicensed personnel to perform these tasks to meet the demand. Currently, trained unlicensed personnel can provide or supervise eight routes of medication administration (enteral, inhaled, ophthalmic, oral, otic, rectal, topical, and transdermal). Currently, unlicensed personnel must complete a 4-hour initial training course in medication administration and have their skills assessed and validated by a registered nurse or physician in each route of administration they intend to use. This assessment includes onsite observation of the administration of medication to or supervision of self-administration by a client.
    [Show full text]
  • Clinical Practice Statements-Oral Contact Allergy
    Clinical Practice Statements-Oral Contact Allergy Subject: Oral Contact Allergy The American Academy of Oral Medicine (AAOM) affirms that oral contact allergy (OCA) is an oral mucosal response that may be associated with materials and substances found in oral hygiene products, common food items, and topically applied agents. The AAOM also affirms that patients with suspected OCA should be referred to the appropriate dental and/or medical health care provider(s) for comprehensive evaluation and management of the condition. Replacement and/or substitution of dental materials should be considered only if (1) a reasonable temporal association has been established between the suspected triggering material and development of clinical signs and/or symptoms, (2) clinical examination supports an association between the suspected triggering material and objective clinical findings, and (3) diagnostic testing (e.g., dermatologic patch testing, skin-prick testing) confirms a hypersensitivity reaction to the suspected offending material. Originators: Dr. Eric T. Stoopler, DMD, FDS RCSEd, FDS RCSEng, Dr. Scott S. De Rossi, DMD. This Clinical Practice Statement was developed as an educational tool based on expert consensus of the American Academy of Oral Medicine (AAOM) leadership. Readers are encouraged to consider the recommendations in the context of their specific clinical situation, and consult, when appropriate, other sources of clinical, scientific, or regulatory information prior to making a treatment decision. Originator: Dr. Eric T. Stoopler, DMD, FDS RCSEd, FDS RCSEng, Dr. Scott S. De Rossi, DMD Review: AAOM Education Committee Approval: AAOM Executive Committee Adopted: October 17, 2015 Updated: February 5, 2016 Purpose The AAOM affirms that oral contact allergy (OCA) is an oral mucosal response that may be associated with materials and substances found in oral hygiene products, common food items, and topically applied agents.
    [Show full text]
  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
    BMJ Open: first published as 10.1136/bmjopen-2020-043675 on 16 February 2021. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 23, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-043675 on 16 February 2021. Downloaded from The Epidemiology of Chronic Pain in Children and Adolescents: A Protocol for a Systematic Review Update Journal: BMJ Open ManuscriptFor ID peerbmjopen-2020-043675 review only Article Type: Protocol Date Submitted by the 11-Aug-2020 Author: Complete List of Authors: Langley, Charlotte; IWK Health Centre,
    [Show full text]
  • Topical Medication Administration
    Wisconsin Department of Public Instruction Medication Administration Assessment for Topical Medication Administration Name: ____________________________________________ Please circle the correct answer and take the completed test to the school nurse or school district administrator for scoring. 1. Which of the following is not a common form of topical skin medication administration in schools? a. Ointment b. Patches c. Solutions d. Gelatin 2. Which of the following is not considered one of the five rights or guidelines to administer medications? a. Right time b. Right drug c. Right location d. Right route 3. What is the most correct sequence of event for administration of a topical medicated patch? a. Wash hands and apply gloves, check the 5 rights, write date, time and initials on patch, open package and apply medicated patch, remove gloves and record on medication administration record. b. Apply gloves, check the 4 rights, open package and apply medicated patch, write date, time and initials on patch, remove gloves and wash hands, and record on medication administration record. c. Record on medication administration record, wash hands and apply gloves, check the first 5 rights, open package and apply medicated patch, write date, time and initials on patch, remove gloves and wash hands. d. Wash hands and apply gloves, check the 5 rights, open package and apply medicated patch, write date, time and initials on patch, remove gloves and wash hands and record on medication administration record. WI DPI 07/06/2016 Wisconsin Department of Public Instruction Medication Administration 4. It is important to report to the school nurse or parent any signs of skin irritation.
    [Show full text]
  • Children and Adolescents with Pain in Primary Care
    ! "# $%!!&"#! ' ( ) ( (''( * ""#!% ! "#$ % $ $& ' $ ()* + ,+ ) # - . /0 ', 1 %2 () 3 ,) !)4 - +& & )5 $ + 0) "66) ) #- ),57"86" 99!6"9) & % % % : $ $ % $ )& % $ $$ $ + : $$ $ % $ + % + ; )* + + % $ + $ $ % $ % 0 % ; % ) , $ 0 % $ $ % + ) * + $ $ 0$ % ) % )< % $ ; % + % % % %) 5 % % + + + $ $ + % )* % $ + $$ $ $$ $ )* $ + +%$ % $ %$ ) = % % + % % + % % )* % %+ + $ 0 % ) 0 % $ $ + + ) *$ %%% $ $ % % ) !"#$ %&"'()*+*,- >, 3 ! ,,7 ?9 ?? ,57"86" 99!6"9 # ### "98' #@@ )0)@ A B # ### "98( To Hanna, Max and Ellen List of Papers This thesis is based on the following papers, referred to in the text by their Roman numerals: I Holm S, Ljungman G, Söderlund A. Pain in children and adolescents in primary care; chronic and recurrent pain is common. Acta Paediatrica. 2012; 101:1246-5. II Holm S, Ljungman G, Åsenlof P, Söderlund A. How children and ado- lescents in primary care cope with pain and the biopsychosocial factors that correlate with pain-related disability.
    [Show full text]
  • Medication Administration
    © adistockShutterStock, Inc. CHAPTER 3 Medication Administration Tara Kavanaugh Medication error KEY TERMS CHAPTER OBJECTIVES Oral Buccal Subcutaneous At the end of the chapter, the reader will be Depot preparations Sublingual able to: Injectable pen Transdermal 1. Define key terms. Intramuscular Transmucosal 2. Discuss the nurse’s role in medication Intraosseous administration. Intravenous 3. Identify the eight medication rights and Medication three patient checks. administration 4. Identify the steps in administering error medications using different delivery methods. 5. Discuss current trends in medication administration. 6. Identify methods to help reduce medication errors. © Jones & Bartlett Learning, LLC. NOT FOR SALE OR DISTRIBUTION. 9781449689391_CH03_055_088.indd 55 08/09/14 10:10 am 56 CHAPTER 3 Medication Administration Introduction Medication is transferred into the body’s tissues in one of three ways: (1) by ingestion and absorption in the digestive tract; (2) by passive transfer through porous tissues, such as the skin, the alveoli of the lungs, and the mucous membranes; or (3) by insertion directly into the interior tissues via subcutaneous, intramuscular, or intrathecal injection or intravenous/intraosseous infusion. The central goal of nursing pharmacology is to enable nurses to provide medications to patients safely and appropriately using the route best suited for the administration. Within that seemingly simple statement is held a complex set of information defining the nurse’s relationship with his or her patients. To safely administer medications, a nurse must States. Contemplating these facts makes it clear that know the answers to a range of potential questions nurses must take an approach toward medicating about his or her patients and their medications: who, patients that focuses on ensuring the right amount what, when, how, and why (TABLE 31).
    [Show full text]
  • The Effect of Diclofenac Mouthwash on Periodontal Postoperative Pain
    Original Article The Effect of Diclofenac Mouthwash on Periodontal Postoperative Pain Jaber Yaghini1, Ahmad Moghareh Abed2, Seyed Abolfazl Mostafavi3, Najmeh Roshanzamir4 ABSTRACT Background: The need to relieve pain and inflammation after periodontal surgery and the side effects of systemic drugs and advantages of topical drugs, made us to evaluate the effect of Diclofenac mouthwash on periodontal postoperative pain. Methods: In this double-blind, randomized clinical trial study 20 quadrants of 10 patients(n = 20) aged between 22-54 who also acted as their own controls, were treated using Modified Widman Flap procedure in two quadrants of the same jaw with one month interval between the operations. After the operation in addition to ibuprofen 400 mg, one quadrant randomly received Diclofenac mouthwash (0/01%) for 30 seconds, 4 times a day (for a week) and for the contrary quadrant, ibupro- fen and placebo mouthwash was given to be used in the same manner. The patients scored the num- ber of ibuprofen consumption and their pain intensity based on VAS index in a questionnaire in days 1, 2, 3 and the first week after operation. The findings were analysed using two-way ANOVA, t-test and Wilcoxon. P-value less than 0.05 considered to be significant. Results: There was a significant difference between the mean values of pain intensity of two quad- rants in four periods (P = 0.031). But, there was no significant difference between the average ibupro- fen consumption in two groups (P = 0.51). Postoperative satisfaction was not significantly different in two quadrants (P = 0.059). 60% of patients preferred Diclofenac mouthwash.
    [Show full text]
  • 35Th Annual Scientific Meeting of the Canadian Pain Society: Abstracts
    35TH ANNUAL SCIENTIFIC MEETING OF THE CANADIAN pain SOCIETY: ABSTRACTS 2. Discussing the prevalence and psychosocial predictors of genito-pelvic pain WEDNESDAY MAY 21, 2014 in women during pregnancy and three months postpartum. SCIENTIFIC PROGRAM, DAY ONE 3. Examining the profile of risk factors and resiliencies important for 9:00 am – 9:45 am adjustment to pain among older adults. 2A 1 AN OVERVIEW OF HOW pediatric pain RESEARCH HAS Keynote SPEAKER: Mary ELLEN JEANS LECTURE GROWN SINCE 1975 LOST IN SPACE? DISRUPTION AND treatment OF Line Caes CORTICAL MAPS OF space AND Body IN PEOPLE WITH Centre for Pediatric Pain Research, IWK Health Centre, Halifax, CHRONIC pain Nova Scotia The field of pediatric pain research has grown tremendously since the first Chair: Jeffrey S Mogil articles on the topic were published in the 1970-80’s, yet no research has EP Taylor Professor of Pain Studies, Canada Research Chair in the been conducted to systematically examine the trends and contributions to Genetics of Pain (Tier I), Department of Psychology and Alan the pediatric pain literature since the early 1990’s. The presentation will Edwards Centre for Pain Research, McGill University, Montreal, focus on a study that employs bibliometric analysis to quantitatively analyze Quebec scientific literature in order to document the impact and trends in pediatric Invited Speaker: G Lorimer Moseley pain research. The goal of the current bibliometric analysis is to provide an Professor of Clinical Neurosciences, Foundation Chair in overview of research on pediatric pain published in peer-reviewed journals Physiotherapy & NHMRC Principal Research Fellow; The University between 1975 and 2010.
    [Show full text]
  • Topical Treatments of Skin Pain Associated with Hidradenitis Supprurativa
    UC Davis Dermatology Online Journal Title Topical treatments of skin pain: a general review with a focus on hidradenitis suppurativa with topical agents Permalink https://escholarship.org/uc/item/4m57506k Journal Dermatology Online Journal, 20(7) Author Scheinfeld, Noah Publication Date 2014 DOI 10.5070/D3207023131 License https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Volume 20 Number 7 July 2014 Review Topical treatments of skin pain: a general review with a focus on hidradenitis suppurativa with topical agents Noah Scheinfeld MD JD Dermatology Online Journal 20 (7): 3 Assistant Clinical Professor of Dermatology Weil Cornel Medical College Correspondence: Noah Scheinfeld 150 West 55th Street NYC NY 10019 (212) 991-6490 [email protected] Abstract Hidradenitis Supprurativa (HS) is a painful chronic follicular disease. Few papers have addressed pain control for this debilitating condition. Possible topical agents include tricyclic antidepressants, opioids, anticonvulsants, NSAIDs, NMDA receptor antagonists, local anesthetics and other agents. The first line agents for the topical treatment of the cutaneous pain of HS are diclonefac gel 1% and liposomal xylocaine 4% and 5% cream or 5% ointment. The chief advantage of topical xylocaine is that is quick acting i.e. immediate however with a limited duration of effect 1-2 hours. The use of topical ketamine, which blocks n- methyl-D-aspartate receptors in a non-competitive fashion, might be a useful tool for the treatment of HS pain. Topical doxepin, which available in a 5% commercially preparation (Zonalon®) , makes patients drowsy and is not useful for controlling the pain of HS .
    [Show full text]
  • Clinical Effectiveness of Compounded Topical Medications in Oral Medicine: a Meta-Analysis
    Margono et al. Stomatological Dis Sci 2020;4:3 Stomatological DOI: 10.20517/2573-0002.2019.18 Disease and Science Meta-Analysis Open Access Clinical effectiveness of compounded topical medications in oral medicine: a meta-analysis Her Basuki Margono1, Irna Sufiawati2 1Oral Medicine Residency Program, Faculty of Dentistry, Padjadjaran University, Bandung 40132, West Java, Indonesia. 2Department of Oral Medicine, Faculty of Dentistry, Padjadjaran University, Bandung 40132, West Java, Indonesia. Correspondence to: Dr. Irna Sufiawati, Department of Oral Medicine, Faculty of Dentistry, Padjadjaran University: Jl. Sekeloa Selatan I, Bandung 40132, West Java, Indonesia. E-mail: [email protected] How to cite this article: Margono HB, Sufiawati I. Clinical effectiveness of compounded topical medications in oral medicine: a meta-analysis. Stomatological Dis Sci 2020;4:3. http://dx.doi.org/10.20517/2573-0002.2019.18 Received: 16 Oct 2019 First Decision: 11 Nov 2019 Revised: 14 May 2020 Accepted: 21 Jul 2020 Published: 19 Aug 2020 Academic Editor: Letizia Perillo Copy Editor: Cai-Hong Wang Production Editor: Jing Yu Abstract Aim: To assess the evidence of the efficacy and safety of compounded topical medications in oral medicine cases. Methods: Electronic databases were searched from inception to October 2019 for studies that evaluated compounded topical medications in oral medicine cases to assess their efficacy and safety. Search terms included drug compounding, topical administration, clinical efficacy, and oral lesions. Only randomized controlled trials (RCTs) or cross-over trials of compounded topical drug versus non-compounded drug or placebo or standard treatment were included. The exclusion criteria included compounded topical medications with herbal ingredients in the intervention group to compare with the non-compounded drug.
    [Show full text]
  • Short-Contact Clobetasol Propionate Shampoo 0.05% Improves Quality of Life in Patients with Scalp Psoriasis
    THERAPEUTICS FOR THE CLINICIAN Short-Contact Clobetasol Propionate Shampoo 0.05% Improves Quality of Life in Patients With Scalp Psoriasis Jerry Tan, MD, FRCPC; Richard Thomas, MD; Béatrice Wang, MD; David Gratton, MD; Ronald Vender, MD; Nabil Kerrouche, MSc; Hervé Villemagne, MSc; for the CalePso Study Team Scalp psoriasis has a considerable impact on the on their QOL increased from 45.6% at baseline to quality of life (QOL) of patients, and most patients 81.7% at week 4. Most participants were satisfied are dissatisfied with available treatments. Clo- with the cosmetic acceptability and the efficacy betasol propionate shampoo 0.05% has been and safety aspects of the product, considered shown to be effective and safe for moderate to it better than prior treatments, and would use it severe scalp psoriasis. We evaluated the effect again in the future. Therefore, we conclude that of clobetasol propionate shampoo on QOL and treatment with clobetasol propionate shampoo the degree of participant satisfaction with the improved the QOL of participants and resulted in product. Participants received once-daily treat- high satisfaction. ment for up to 4 weeks. Their QOL and degree Cutis. 2009;83:157-164. of satisfaction were evaluated by questionnaires. The mean (standard deviation) Dermatology Life Quality Index (DLQI) score decreased signifi- calp psoriasis is a common inflammatory disease cantly from 7.0 (4.9) at baseline to 3.2 (3.2) at that has a considerable impact on the quality of week 4 (P,.001). Participants who considered S life (QOL) of patients because of its associated the disease as having a small effect or no effect pruritus, the visibility of lesions, and the chronicity of disease.1 Approximately 50% of patients in one Accepted for publication January 26, 2009.
    [Show full text]